Elke Therapeutics Inc. is a Bio-Pharma , drug hunting company.We are striving to treat & out right cure key diseases.
Founder: S.Elvira Davis MS. Biochemist with Biotech/Microsurgery expertise.
Tech:, Holistic AI / Medicinal Chem analysis has led to our discovery of novel drug leads & personalized supplement solutions.
Core areas: Long CV complications, Brain health ( PTSD , Depression) , Nootropic Dynamics, Cancer Resistance & Pain ( N.Opioid) . Maternal health decline.
Reasons to join our journey:
Use of honest chemical innovation, De-risking methods to advance safer products.
*Financials: E.T. is structured to be a low risk investment opportunity with a good ROI expected in appox. 7 months.
Lab space in DC / Baltimore tech ECOSYSTEM .
Values : Employ ,disciplined use of funds ,impact health disparities & provide key economic benefits in the U.S.
Internal Platform: New approaches attack signalling & structural challenges with novel formulations.
Have lab space opportunities in DC Region
To join us on our innovation journey :
Contact-sdavisp40@gmail.com
Company Details
- Founded
- -
- Address
- 99 Wall Street,
- Industry
- Biotechnology
- HQ
- NYC, NY
Elke Therapeutics Inc Questions
Elke Therapeutics Inc's LinkedIn profile is https://www.linkedin.com/company/elke-therapeutics
Elke Therapeutics Inc's industry is
Biotechnology
Elke Therapeutics Inc's top competitors are
Wrs Therapeutics,
Kaura Therapeutics,
Advanced Therapeutics Usa,
Perseus Therapeutics, Inc.,
Keren Therapeutics,
Jillion Therapeutics Inc.,
Folligenz Therapeutics,
Loop Therapeutics,
Anterios Therapeutics,
Sarentis Therapeutics, Inc..
Elke Therapeutics Inc's categories are Biotechnology
Elke Therapeutics Inc's founding year is 2018
